Market Tracker

08/20 12:32pm ET

Theravance Inc (NASDAQ:THRX)

23.19
Real-Time Quote
 -0.11 / -0.47%
Today’s Change
20.23
Today|||52-Week Range
34.52
-19.25%
Year-to-Date

Today’s Trading

Previous close23.30
Today’s open23.17
Day’s range22.92 - 23.31
Volume130,717
Average volume (3 months)1,156,604
Market cap$2.7B
Dividend yield4.31%
Data as of 12:16pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+38.44%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book8.69

Competitors

 Today’s
change
Today’s
% change
WXWuXi Pharmatech (Cay...+0.27+0.73%
MYGNMyriad Genetics Inc+0.46+1.25%
MNKDMannkind Corp-0.03-0.34%
NPSPNPS Pharmaceuticals ...+0.11+0.40%
Data as of 12:28pm ET, 08/20/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts